HTG Molecular

$6.01
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.33 (-5.21%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell HTG Molecular and other stocks, options, and ETFs commission-free!

About HTGM

HTG Molecular Diagnostics, Inc. engages in the provision of molecular technology solutions that facilitates molecular profiling. It offers instruments, reagents and services for molecular profiling applications. The firm serves biopharmaceutical companies, academic research centres, and molecular testing laboratories. Its proprietary HTG EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. The company was founded by Bruce E. Seligmann in October 1997 and is headquartered in Tucson, AZ. The listed name for HTGM is HTG Molecular Diagnostics, Inc. Common Stock.

CEO
John L. Lubniewski
Employees
112
Headquarters
Tucson, Arizona
Founded
1997
Market Cap
26.39M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
154.98K
High Today
$6.59
Low Today
$5.64
Open Price
$6.44
Volume
150.83K
52 Week High
$13.80
52 Week Low
$3.78

HTGM Earnings

-$0.17
-$0.11
-$0.06
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 24, After Hours

You May Also Like

FDL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure